血液测试可能成为诊断 CTE 的革新工具
'Game changer' blood test for CTE may be coming
研究发现血液中特定蛋白 eMTBR-tau 可能用于诊断 CTE,但该测试尚未获批。研究团队在 JAMA 发表了相关论文。
研究团队发现血液中特定蛋白可作为 CTE 的生物标志物,未来可能用于生前诊断,但尚未获批。
Traces of a brain protein in blood could soon lead to a test that could diagnose chronic traumatic encephalopathy (CTE) during a person's lifetime. CTE is a degenerative brain disease best known for affecting football players.
Right now, CTE can only be diagnosed via autopsy after death. One recent autopsy-based study found that nearly 75% of deceased former NFL players had been affected by CTE.
The illness is linked to repeat head injury and can lead to cognitive impairment, behavioral changes, mood swings and dementia.
A blood-based test that could spot CTE while players are still alive could be "a game changer," said study co-senior author Michael Alosco, co-director of clinical research at Boston University's CTE Center.
The test is not yet approved by the U.S. Food and Drug Administration (FDA).
"We are still in the discovery phase, and it's a small sample size, but if future studies validate these findings, this blood test will allow us to detect CTE with a high level of accuracy and open the doors to clinical trials and treatment," Alosco said in a university news release.
His team published its findings in JAMA.
The researchers based their findings on blood tests conducted with 21 former American football players while they were still alive. All had donated their brains for research, and 18 of the players' brains revealed the presence of CTE.
The blood test is designed to spot traces of a brain protein abbreviated as eMTBR-tau. The protein is already known to spur tau "tangles" in the brains of people affected by Alzheimer's disease.
Of the 18 deceased players whose autopsies showed signs of CTE, 16 had late-stage disease and two had early-stage CTE.
Blood tests showed elevated eMTBR-tau for those players with later-stage CTE, but not for those diagnosed with early-stage or no CTE, the researchers said.
Alosco's team noted that some of the deceased players hadn't played professionally, only at the high school or college level. Nevertheless, a majority of the college-level players had later-stage CTE, as did one of the two men who'd only played during high school.
Five of the players who'd had CTE had also been diagnosed with Alzheimer's disease, the research showed, and blood levels of eMTBR-tau were highest among players diagnosed with both illnesses.
"Having blood tests that accurately determine the underlying pathology, which are now approved for use, has been revolutionary in the way we diagnose patients and design therapeutic trials that aim to combat Alzheimer's disease," noted Nicholas Ashton, co-senior author of the study and senior director of Banner Health's Fluid Biomarker Program. "With this new study, we are optimistic that the same will be true for CTE."
Reporting in JAMA, a second team found similar results in a separate study of blood levels of eMTBR-tau243, another potential marker for CTE.
"We are excited by both sets of findings," said Annalise Miner, a behavioral neuroscience Ph.D. student working at Alosco's lab who co-authored the new study.
In the news release, she cautioned that "it is important for the public to know that the blood test is not currently FDA-approved, nor is it available to the public and should not be used or attempted to be used to make diagnostic decisions about CTE until validation studies are completed."
In the meantime, anyone concerned about their risk for CTE should consider evaluation by a specialist in neurodegenerative conditions, the research team said.
Publication details
Annalise E. Miner et al., Plasma eMTBR-tau as a Biomarker for Chronic Traumatic Encephalopathy Tau Tangle Neuropathology, JAMA (2026). DOI: 10.1001/jama.2026.24780
Wagner S. Brum et al., A Plasma eMTBR-Tau Immunoassay for Detection of Advanced Insoluble Tau Pathology, JAMA (2026). DOI: 10.1001/jama.2026.25143
Journal information: Journal of the American Medical Association
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Copyright © 2026 HealthDay. All rights reserved.
Citation: 'Game changer' blood test for CTE may be coming (2026, November 20) retrieved 20 November 2026 from https://medicalxpress.com/news/2026-11-game-changer-blood-cte.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com